Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Sadot Group | SDOT | Oct 31, 2024 | 2.76 | +6.15 |
Safe & Green Holdings | SGBX | Oct 31, 2024 | 0.94 | -6.92 |
Safe And Green Development | SGD | Oct 31, 2024 | 2.97 | -7.76 |
Safe Bulkers | SB | Oct 31, 2024 | 4.19 | -0.48 |
Safe Bulkers Pref C | SB-C | Oct 31, 2024 | 25.85 | 0.00 |
Safe Bulkers Pref D | SB-D | Oct 31, 2024 | 25.80 | +0.39 |
Safe Pro Group | SPAI | Oct 31, 2024 | 2.25 | 0.00 |
Safehold | SAFE | Oct 31, 2024 | 21.28 | -4.01 |
Safety Insurance Group | SAFT | Oct 31, 2024 | 78.27 | -0.69 |
Safety Shot | SHOT | Oct 31, 2024 | 0.99 | -6.02 |
SAG Holdings Limited - Ordinary Shares | SAG | Oct 31, 2024 | 3.66 | 0.00 |
Saga Communications A | SGA | Oct 31, 2024 | 14.01 | -2.10 |
Sage Therapeutics | SAGE | Oct 31, 2024 | 6.08 | -5.59 |
Sagimet Biosciences | SGMT | Oct 31, 2024 | 5.15 | -3.56 |
SAI.TECH Global | SAI | Oct 31, 2024 | 0.75 | 0.00 |
Saia | SAIA | Oct 31, 2024 | 488.61 | -0.55 |
SAIHEAT A | SAIH | Oct 31, 2024 | 1.12 | 0.00 |
Salarius Pharmaceuticals | SLRX | Oct 31, 2024 | 1.61 | -0.62 |
Salesforce | CRM | Oct 31, 2024 | 291.37 | -1.70 |
Sally Beauty | SBH | Oct 31, 2024 | 13.00 | -3.63 |
Samfine Creation Group | SFHG | Oct 31, 2024 | 11.54 | 0.00 |
Samsara A | IOT | Oct 31, 2024 | 47.79 | -3.16 |
San Juan Basin Royalty Trust Unit | SJT | Oct 31, 2024 | 4.01 | -1.47 |
Sana Biotechnology | SANA | Oct 31, 2024 | 3.50 | -4.37 |
Sanara MedTech | SMTI | Oct 31, 2024 | 33.00 | +0.76 |
SandRidge Energy | SD | Oct 31, 2024 | 11.09 | -0.81 |
Sandstorm Gold | SAND | Oct 31, 2024 | 6.05 | -0.17 |
Sandy Spring Bancorp | SASR | Oct 31, 2024 | 33.64 | -1.35 |
Sangamo Therapeutics | SGMO | Oct 31, 2024 | 1.70 | -14.57 |
Sangoma Technologies | SANG | Oct 31, 2024 | 6.00 | -0.33 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.